Fed. Circ. Urged To Rehear Jurisdiction Ruling On Generics
The Generic Pharmaceutical Association has urged the Federal Circuit to reconsider its recent decision to require Mylan to face patent infringement suits over two planned generic drugs in the District of...To view the full article, register now.
Already a subscriber? Click here to view full article